Lantheus Medical Imaging has promoted Mary Anne Heino to chief operating officer (COO), a newly created position in the company, effective March 16.
Heino has served as chief commercial officer since April 2013 and will continue to report to Jeff Bailey, Lantheus' president and CEO.
As COO, Heino will oversee the daily management of all operations that manufacture, sell, and distribute Lantheus' products. In addition to her current responsibilities, Heino will assume leadership for manufacturing and operations, and she will be responsible for integration with quality and regulatory affairs.
Heino has more than 25 years of pharmaceutical and biotech industry experience. Prior to joining Lantheus in 2013, she was president of Angelini Labopharm, an international pharmaceutical joint venture, with responsibility for commercial, manufacturing, quality, regulatory affairs, and other functions. She was also instrumental in setting up the company's supply chain, Lantheus said.
